Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

September 30, 2009

Conditions
Contact Dermatitis
Interventions
BIOLOGICAL

T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens

"Disperse blue 106 in PVP, 0.15 mg/cm2 Disperse blue 106 in PVP, 0.050 mg/cm2 Disperse blue 106 in PVP, 0.017 mg/cm2 PVP Negative Control Bronopol in PVP, 0.75 mg/cm2 Bronopol in PVP, 0.50 mg/cm2 Bronopol in PVP, 0.25 mg/cm2 Bronopol in PVP, 0.125 mg/cm2~Test patches, with allergens, are placed at day one and removed 48 hours later. The duration of the study lasts 21 days. However, the subject is only exposed to the study allergens for 48 hours."

Trial Locations (2)

40202-1864

Dermatology Specialists PSC, Louisville

DK-5000

Odense University Hospital, Odense C

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allerderm

INDUSTRY

NCT00640250 - Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response | Biotech Hunter | Biotech Hunter